“…[9] In 2009, Kiselyov and collaborators reported the design and chemical synthesis of [1,2,4]triazol [1,5-c]pyrimidin-5-yl amines, a novel class of VEGFR-2 kinase inhibitors, (E)-2-(5-methyl-4H-1,2,4triazol-3-yl)-3-(pyridin-4-yl)acrylonitrile (IIc) (Figure 1) being one of the key intermediate for their synthesis. [11] They easily prepared it by Knoevenagel condensation of 2-(5-methyl-4H-1,2,4-triazol-3-yl)acetonitrile with 4-pyridylaldehyde, and obtained it as a major trans-isomer, in 71-75 % yield. Finally, it is interesting to note that compounds of type III (Figure 1) have been prepared by reaction of 5-benzyl-1H-1,2,4-triazol-3-ylacetonitrile with aromatic aldehydes, and tested for their hypotensive effect in rats.…”